Patients treated with Enbrel should be given the Patient Card.
The recommended dose of Enbrel for adult patients with plaque PsO is:1
Treatment with Enbrel should continue until remission is achieved, for up to 24 weeks.
Continuous therapy beyond 24 weeks may be appropriate for some adult PsO patients.1
Treatment should be discontinued in PsO patients who show no response after 12 weeks. If re-treatment with Enbrel is indicated, the same guidance on treatment duration should be followed. The dose should be 25 mg twice weekly or 50 mg once weekly.1
Learn more about the efficacy and safety of Enbrel in PsO
Pfizer has resources available to support you and your Enbrel patients
Legal Category: S1A
Further information is available upon request
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023